Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anorexia × Olanzapine × Clear all

Phase

Status

Recruiting 3 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 5 Nausea 5 Breast Neoplasms 3 Neoplasms 2 Hematologic Neoplasms 2 Weight Loss 1 Sedentary Behavior 1 Postoperative Nausea and Vomiting 1 Neoplasms, Plasma Cell 1 Muscular Atrophy 1 Multiple Endocrine Neoplasia Type 1 1 Insulin Resistance 1 Hyperlipidemias 1 Hyperglycemia 1 Delirium 1 Child Nutrition Disorders 1 Cachexia 1 Anorexia 1 Advanced Cancer 1

Interventions

Megestrol Acetate 4 Mirtazapine 2 Infliximab 2 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Palonosetron 1 Olanzapine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Gemcitabine 1 Etanercept 1 Eicosapentaenoic Acid 1 Docetaxel 1 Creatine 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05243251 2024-10-03

Olanzapine Anorexia Cachexia

Cairo University

Phase 3 Completed

Anorexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡